Full Length Research Paper
References
|
Aung ZZ, Oo MM, Tripathy JP, Kyaw NTT, Hone S, Oo HN (2018). Are death and loss to follow-up still high in people living with HIV on ART after national scale-up and earlier treatment initiation? A large cohort study in government hospital-based setting, Myanmar: 2013-2016. PLOS ONE 13(9):e0204550. |
|
|
Baldé A, Lièvre L, Maiga AI, Diallo F, Maiga IA, Costagliola D (2019).. Risk factors for loss to follow-up, transfer or death among people living with HIV on their first antiretroviral therapy regimen in Mali. HIV Medication 20(1):47?53. |
|
|
Bekolo CE, Webster J, Batenganya M, Sume GE, Kollo B (2013). Trends in mortality and loss to follow-up in HIV care at the Nkongsamba Regional hospital, Cameroon. BMC Research Notes 6(1):512. |
|
|
Bernède M (2011). Les «?perdus de vue?» en Afrique?: quelles réponses?? Transversal P 57. |
|
|
Birhanu A, Dingeta T, Tolera M (2021). Predictors of Mortality Among Adult HIV-Infected Patients Taking Antiretroviral Therapy (ART) in Harari Hospitals, Ethiopia. HIVAIDS - Res Palliat Care. Juill 13:727-736. |
|
|
Blevins M, José E, Bilhete FR, Vaz LME, Shepherd BE, Audet CM (2015). Two-Year Death and Loss to Follow-Up Outcomes by Source of Referral to HIV Care for HIV-Infected Patients Initiating Antiretroviral Therapy in Rural Mozambique. AIDS Research and Human Retroviruses Févr 31(2):198?207. |
|
|
Bognounou R, Kabore M, Diendéré A, Diallo I, Sagna Y, Guira O (2015). Caractéristiques des patients «?perdus de vue?» et facteurs déterminants de la perte de vue au cours du suivi des patients infectés par le VIH à Ouagadougou, Burkina Faso. Bulletin de la Société de Pathologie Exotique 108(3). |
|
|
Damtew B, Mengistie B, Alemayehu T (2015). Survival and determinants of mortality in adult HIV/Aids patients initiating antiretroviral therapy in Somali Region, Eastern Ethiopia. Pan African Medical Journal [Internet]. 2015 [cité 21 mai;22. Disponible sur: |
|
|
De Sousa Moreira JA (2015). Co-trimoxazole in people on antiretroviral therapy for HIV. Lancet HIV 2(6):e227. |
|
|
District sanitaire de Boromo (2018). Plan d'action du district sanitaire de Boromo. |
|
|
Fiche d'information (2020) Dernières statistiques sur l'état de l'épidémie de sida [Internet]. [cité 18 janv Disponible sur: |
|
|
Focus (2020). sur le Burkina Faso [Internet]. [cité 5 oct. Disponible sur: |
|
|
Fox MP, MPA SR (2015). Retention of Adult Patients on Antiretroviral Therapy in Low- and Middle-Income Countries: Systematic Review and Meta-analysis 2008-2013. Journal of Acquired Immune Deficiency Syndromes 69(1):98-108. |
|
|
Grimsrud A, Balkan S, Casas EC, Lujan J, Van Cutsem G, Poulet E (2014). Outcomes of Antiretroviral Therapy Over a 10-Year Period of Expansion: A Multicohort Analysis of African and Asian HIV Programs. JAIDS Journal of Acquired Immune Deficiency Syndromes 67(2):e55. |
|
|
Hønge BL, Jespersen S, Nordentoft PB, Medina C, da Silva D, da Silva ZJ (2013). Loss to follow-up occurs at all stages in the diagnostic and follow-up period among HIV-infected patients in Guinea-Bissau: a 7-year retrospective cohort study. BMJ Open 3(10):e003499. |
|
|
Kibuuka H, Musingye E, Mwesigwa B, Semwogerere M, Iroezindu M, Bahemana E (2022). Predictors of All-Cause Mortality Among People With Human Immunodeficiency Virus (HIV) in a Prospective Cohort Study in East Africa and Nigeria. Clinical Infectious Diseases 75(4):657?664. |
|
|
Kouanda S, Meda IB, Nikiema L, Tiendrebeogo S, Doulougou B, Kaboré I (2012). Determinants and causes of mortality in HIV-infected patients receiving antiretroviral therapy in Burkina Faso: a five-year retrospective cohort study. AIDS Care 24(4):478?490. |
|
|
Marlink R, Kanki P, Thior I, Travers K, Eisen G, Siby T (1994). Reduced rate of disease development after HIV-2 infection as compared to HIV-1 [Internet]. Vol. 265, Science (New York, N.Y.). Science 1994 [cité 28 sept 2020]. Disponible sur: |
|
|
Mekonnen N, Abdulkadir M, Shumetie E, Baraki AG, Yenit MK (2019). Incidence and predictors of loss to follow-up among HIV infected adults after initiation of first line anti-retroviral therapy at University of Gondar comprehensive specialized Hospital Northwest Ethiopia, 2018: retrospective follow up study. BMC Research Notes 12(1):111. |
|
|
Ministère de la santé Burkina Faso (2018). Normes et protocole VIH_5è Edition. |
|
|
Odafe S, Idoko O, Badru T, Aiyenigba B, Suzuki C, Khamofu H (2012). Patients' demographic and clinical characteristics and level of care associated with lost to follow-up and mortality in adult patients on first-line ART in Nigerian hospitals. Journal of the International AIDS Society 15(2):17424. |
|
|
OMS (2017). Lignes directrices unifiées sur le suivi des patients infectés par le VIH et la surveillance des cas selon une approche centrée sur la personne [Internet]. Disponible sur: |
|
|
OMS (2020). Indicateurs d'alerte précoce de résistance du VIH aux antiretroviraux [Internet]. WHO. World Health Organization; [cité 4 oct. Disponible sur: |
|
|
ONUSIDA (2014). 90-90-90 Une cible ambitieuse de traitement pour aider à mettre fin à l'épidémie du sida [Internet]. Disponible sur: |
|
|
Organisation mondiale de la Santé (2018). Evaluation de la qualité des données et des systèmes du niveau national et des partenaires relatifs au traitement de l'infection à VIH et au suivi des patients: outil de mis en œuvre [Internet]. 2018 [cité 12 mars]. Disponible sur: |
|
|
Putter H, Fiocco M, Geskus RB (2007). Tutorial in biostatistics: competing risks and multi-state models. Statistics in Medicine. 26(11):2389?430. |
|
|
Roura M, Busza J, Wringe A, Mbata D, Urassa M, Zaba B (2009). Barriers to Sustaining Antiretroviral Treatment in Kisesa, Tanzania. AIDS Patient Care STDs 23(3):203?210. |
|
|
Schepens T, Morreel S, Florence E, Koole O, Colebunders R (2010). Incidence and risk factors associated with lost to follow-up in a Belgian cohort of HIV-infected patients treated with highly active antiretroviral therapy. International Journal of STD and AIDS 21(11):765?769. |
|
|
Suthar AB, Granich R, Mermin J, Van Rie A (2012). Effect of cotrimoxazole on mortality in HIV-infected adults on antiretroviral therapy: a systematic review and meta-analysis. Bulletin of the World Health Organization 90(2):128-138C. |
|
|
Teshale AB, Tsegaye AT, Wolde HF (2021). Incidence of Mortality and Its Predictors Among HIV Positive Adults on Antiretroviral Therapy in University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia. HIV/AIDS - Research and Palliative Care 13:31?39. |
|
|
Tiruneh YM, Galárraga O, Genberg B, Wilson IB (2020). Retention in Care among HIV-Infected Adults in Ethiopia, 2005- 2011: A Mixed-Methods Study. PLoS ONE [Internet]. 11(6). Disponible sur: |
|
|
Tran DA, Ngo AD, Shakeshaft A, Wilson DP, Doran C, Zhang L (2013). Trends in and Determinants of Loss to Follow Up and Early Mortality in a Rapid Expansion of the Antiretroviral Treatment Program in Vietnam: Findings from 13 Outpatient Clinics. PLOS ONE. 8(9):e73181. |
|
|
Walker AS, Ford D, Gilks CF, Munderi P, Ssali F, Reid A (2010). Daily co-trimoxazole prophylaxis in severely immunosuppressed HIV-infected adults in Africa started on combination antiretroviral therapy: an observational analysis of the DART cohort. Lancet 375(9722):1278. |
|
|
Wolff MJ, Giganti MJ, Cortes CP, Cahn P, Grinsztejn B, Pape JW (2017). A decade of HAART in Latin America: Long term outcomes among the first wave of HIV patients to receive combination therapy. PLoS One 12(6). |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
